Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Presley

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Cancer Immunology, Immunotherapy : CII|October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survivalTyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
Journal of Cancer Survivorship : Research and Practice|September 5, 2023
Changes in physical function in older women with endometrial cancer with or without adjuvant therapyAllison M Quick, Eric McLaughlin, Jessica L Krok Schoen, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapyAdam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Cancer Investigation|October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint InhibitorsSandip H Patel, Songzhu Zhao, Mingjia Li, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Biomedicines|September 23, 2022
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint InhibitorsJennifer K Matsui, Haley K Perlow, Rohit K Raj, et al.
Journal of Geriatric Oncology|September 17, 2024
Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort studySurbhi Singhal, Louise C Walter, Alexander K Smith, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|October 7, 2021
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survivalTyler C Haddad, Songzhu Zhao, Mingjia Li, et al.
Journal of Cancer Survivorship : Research and Practice|September 5, 2023
Changes in physical function in older women with endometrial cancer with or without adjuvant therapyAllison M Quick, Eric McLaughlin, Jessica L Krok Schoen, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Oncoimmunology|February 21, 2025
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patientsAnet Greib, Songzhu Zhao, Michelle Ploch, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2025
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapyAdam Khorasanchi, Mingjia Li, Songzhu Zhao, et al.
Cancer Investigation|October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint InhibitorsSandip H Patel, Songzhu Zhao, Mingjia Li, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Biomedicines|September 23, 2022
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint InhibitorsJennifer K Matsui, Haley K Perlow, Rohit K Raj, et al.
Journal of Geriatric Oncology|September 17, 2024
Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort studySurbhi Singhal, Louise C Walter, Alexander K Smith, et al.
Pageof 19